Document Detail


Management of ST-segment elevation myocardial infarction: Comparison of the updated guidelines from North America and Europe.
MedLine Citation:
PMID:  19853685     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The American College of Cardiology/American Heart Association and the European Society of Cardiology each recently published updated guidelines for management of patients with acute ST elevation myocardial infarction. In this article, we highlight the most important new recommendations, review their supporting data, and describe differences between the guidelines. Key aspects of these updates include detailed guidance regarding the selection of a reperfusion strategy and the incorporation of newer adjunctive antithrombotic agents. Both new guidelines suggest caution in the administration of intravenous beta-blockers, avoidance of nonsteroidal anti-inflammatory agents, and support a more aggressive approach to secondary risk factor management. The 2 guidelines have some nuanced differences as well as some recommendations that are unique to each guideline. They present different levels of support for the 4 available adjunctive parenteral anticoagulants, vary in their endorsement of routine elective coronary angiography after fibrinolysis, and cite different targets for low density lipoprotein long-term. Major unique recommendations include the American College of Cardiology/American Heart Assocaition's emphasis of a stepped approach to analgesia in patients with musculoskeletal pain beginning with acetaminophen or aspirin and a lower target international normalized ratio in patients receiving warfarin, aspirin, and clopidogrel. Meanwhile, unique recommendations in the European Society of Cardiology guidelines include measures to prevent/treat microvascular obstruction and reperfusion injury associated with percutaneous coronary intervention and greater emphasis on maintaining eugylcemia. As these guidelines represent an evidence based approach, health care providers should become familiar with the new data and the resultant updated recommendations to ensure optimal treatment of their patients with ST-elevation myocardial infarction.
Authors:
Deepak Thomas; Robert P Giugliano
Related Documents :
10650315 - Clinical challenges of platelet glycoprotein iib/iiia receptor inhibitor therapy: bleed...
8321905 - The role of antiplatelet therapy in acute coronary syndromes and for secondary preventi...
11214765 - Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review.
9737475 - Rationale for the management of coronary syndromes with low-molecular-weight heparins.
14978775 - Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gen...
15295725 - Efficacy of lower-energy biphasic shocks for transthoracic defibrillation: a follow-up ...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  American heart journal     Volume:  158     ISSN:  1097-6744     ISO Abbreviation:  Am. Heart J.     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-26     Completed Date:  2009-12-31     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  United States    
Other Details:
Languages:  eng     Pagination:  695-705     Citation Subset:  AIM; IM    
Affiliation:
Brigham and Women's Hospital, Boston, MA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
American Heart Association
Electrocardiography
Europe
Humans
Myocardial Infarction / diagnosis*,  therapy*
North America
Practice Guidelines as Topic*
United States

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of live-attenuated Salmonella vaccines expressing Campylobacter antigens for control of C...
Next Document:  Magnitude and consequences of missing the acute infarct-related circumflex artery.